(Alliance News) - Immunotherapy-focused pharmaceutical company Midatech Pharma PLC said Monday it has appointed Stephen Stamp as chief financial officer with immediate effect.
He will be replacing Nick Robbins-Cherry, who stepped down from his role after five years in the role since 2014. Robbins-Cherry will remain at Midatech until October to facilitate an orderly handover.
Stamp was most recently chief executive officer of pharmaceutical services firm Ergomed PLC for two years since 2017, stepping down in January due to health reasons. Prior to that he was chief financial officer at Ergomed for a year from 2016 to 2017.
Before then, he was chief financial officer of US-based personalised medicine group AssureRx Health Inc, for three years from 2013 to 2016.
In the past, Stamp was the finance director of office space provider Regus PLC and former London-listed pharmaceutical firm Shire PLC.
"The directors are delighted to welcome Stephen Stamp to the board of Midatech as CFO. He brings a wealth of relevant financial, commercial and industry experience gained in a wide range of senior roles at major healthcare companies, in the UK and internationally, which will enable him to make a significant contribution to Midatech's future success. This is an exciting time for the company and having someone of Stephen's financial pedigree joining will be a real asset," said Chair Rolf Stahel.
Shares in Midatech Pharma were untraded on Monday, last quoted at 5.59 pence in London.
